* Prophase Labs Inc PRPH.OQ PRPH.O is expected to report
results on November 12.
* The New York City, New York-based company is expected to
report revenue of $9.076 million, according to the estimate from
one analyst, based on Refinitiv data.
* Refinitiv's mean analyst estimate for Prophase Labs Inc is
for earnings of 7 cents per share.
* The current average analyst rating on the shares is "hold" and
the breakdown of recommendations is no "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in the
last three months.
* Wall Street's median 12-month price target for Prophase Labs
Inc is $12.5, about 53.7% above its last closing price
of $5.79.
This summary was machine generated November 10 at 14:05 GMT.
All figures in US dollars unless otherwise stated